Search tips
Search criteria 


Logo of cytotechspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
Cytotechnology. 2000 February; 32(2): 157–167.
PMCID: PMC3449690

The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells


Protein hydrolysates as substitutes for serum havebeen employed by many in cell culture mediumformulation, especially with the shift to low proteinor protein-free media. More recently, vegetablehydrolysates have also been added as nutritionalsupplements to fortify the amino acid content in smallpeptide form for batch and fed-batch fermentations. Several of these new hydrolysates (peptones of soy,rice, wheat gluten etc.) were tested as protein-freemedium supplements for the production of a recombinanttherapeutic protein. Multiple peptone-supplemented,continuous perfusion bioreactor experiments wereconducted, varying dilution rates and basal mediumcomposition over the various runs. Cell specificrates and product quality studies were obtained forthe various peptones and compared with peptone-freemedium. The potential for peptones to decreaseintrinsic and proteolytic degradation of the productwas also investigated.It was found that peptones confer a nutritionalbenefit, especially at low dilution rates, for therecombinant BHK cell line used in this investigation.The specific productivity increased 20–30% comparedto the peptone-free controls. However, this benefitwas also fully delivered by using fortified medium inplace of the peptone-enriched media. Therefore, whilepeptones may be considered as useful medium additiveswhen development time is limited, their addition maybe avoided by systematic medium development ifpermitted by the time line of the project.

Full Text

The Full Text of this article is available as a PDF (328K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Amatsuji Y, Tamashima H & Uemura Y (1998) A serum-free containing insulin and peptone improved medium for animal cell culture, used for production of e.g. hepatitis B virus surface antigen, monoclonal antibody. Green Cross, Patent 1998, WO 9800521.
  • Bonarius H, Hatzimanikatis V, Meesters KD, de Gooijer K, Schmid G & Tramper J (1996) Metabolic flux analysis of hybridoma cells in different culture media using mass balances. Biotechnol Bioeng 50: 299–318.
  • Brandsch M, Ganapathy V, Leibach F. H+-peptide cotransport in Madin-Darby canine kidney cells: Expression and calmodulin-dependend regulation. Am J Physiol. 1995;268:F391–F397. [PubMed]
  • Brandsch M, Brandsch C, Prasad P, Ganapathy V, Hopfer U, Leibach F. Identification of a renal cell line that constitutively expresses the kidney-specific high-affinity H+/peptide cotransporter. FASEB J. 1995;9:1489–1496. [PubMed]
  • Büntemeyer H, Lütkemeyer D, Lehmann J. Optimization of serum free fermentation processes for antibody production. Cytotechnology. 1991;5:57–67.
  • Chuppa S, Tsai Y-S, Yoon S, Shackleford S, Rozales C, Bhat R, Tsay G, Matanguihan C, Konstantinov K, Naveh D. Fermentor temperature as a tool for control of high-density perfusion cultures of mammalian cells. Biotechnol Bioeng. 1997;55:328–338. [PubMed]
  • Dyring C, Hansen H, Emborg C. Observations on the influence of glutamine, asparagine and peptone on growth and t-PA production of Chinese hamster ovary (CHO) cells. Cytotechnology. 1994;16:37–42. [PubMed]
  • Ganapathy V, Leibach F. Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit. J Biol Chem. 1883;258:14189–14192. [PubMed]
  • Ganapathy V, Leibach F. Carrier-mediated reabsorption of small peptides in renal proximal tubule. Am J Physiol. 1986;251:F945–F953. [PubMed]
  • Gu X, Xie L, Harmon B, Wang D. Influence of Primatone RL supplementation on sialylation of recombinant human interferon-produced by Chinese hamster ovary cell culture using serum-free media. Biotechnol Bioeng. 1997;56:353–360. [PubMed]
  • Hardy M, Townsend R. Seperation of positional isomeres of oligosaccharides and glycopeptides by high-performance anionexchange chromatography with pulsed amperometric detection. Proc Natl Acad Sci USA. 1988;85:3289–3293. [PubMed]
  • Heidemann R, Lütkemeyer D, Büntemeyer H & Lehmann J (1995) Determination of KS-values (Monod constants) for essential amino acids using CHO and hybridoma cells in batch and chemostat cultures. In: Beuvery EC, Griffiths JB & Zeijlemaker WP (eds.) Animal Cell Technology: Development Towards the 21stCentury (pp. 735–739).
  • Heidemann R, Lütkemeyer D, Büntemeyer H, Lehmann J. Effects of dissolved oxygen levels and the role of extra-and intracellular amino acid concentrations upon the metabolism of mammalian cell lines during batch and continuous cultures. Cytotechnology. 1998;26:185–197. [PMC free article] [PubMed]
  • Hopfer U. Digestion and obsorption of basic nutritional constituents. In: Delwin TM, editor. Textbook of Biochemistry with Clinical Correlations. Fourth edition. New York: Wiley-Liss; 1997. pp. 1055–1086.
  • Hughes S, Johnson D. Amperometic detection of simple carbohydrates at platinum electrodes in alkaline solutions by application of a triple-pulse potential waveform. Anal Chim Acta. 1981;132:11–22.
  • Jan D, Jones S, Emery A, Al-Rubeai M. Peptone, a low cost growth-promoting nutrient for intensive animal cell culture. Cytotechnology. 1994;16:17–26. [PubMed]
  • Keen M, Rapson N. Development of a serum-free culture medium for the large scale production of recombinant protein from Chinese hamster ovary cell line. Cytotechnology. 1995;17:153–163. [PubMed]
  • Kempken R, Büntemeyer H, Lehmann J. The medium cycle reactor (MCB): Monoclonal antibody production in a new economic production system. Cytotechnology. 1991;7:63–74. [PubMed]
  • Kuhlmann W. Optimization of a membrane oxygenation system for cell culture stirred tank reactors. Dev Biol Standard. 1988;66:262–268.
  • Nyberg G, Balcarcel R, Follstad B, Stephanopoulos G, Wang D. Metabolism of peptide amino acids by Chines hamster ovary cells grown in a complex medium. Biotechnol Bioeng. 1999;62:324–335. [PubMed]
  • Ramamoorthy S, Liu W, Ma Y-Y, Yang-Feng T, Ganapathy V, Leibach F. Proton/peptide cotransporter (PEPT 2) from human kidney: Functional characterization and chromosomal localization. Biochim Biophys Acta. 1995;1240:1–4. [PubMed]
  • Riese U, Lütkemeyer D, Heidemann R, Büntemeyer H, Lehmann J. Re-use of spent cell culture medium in pilot scale and rapid preparative purification with membrane chromatography. J Biotechnol. 1994;34:247–257. [PubMed]
  • Rønning Ø, Schartum M, Winsnes A, Lindberg G. Growth limitation in hybridoma cell culture: The role of inhibitory or toxic metabolites. Cytotechnology. 1991;7:15–24. [PubMed]
  • Schlaeger E-J. The protein hydrolyzate, Primatone RL, is a cost-effect multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties. J Immunol Methods. 1996;194:191–199. [PubMed]
  • Silbernagl S, Ganapathy V, Leibach F. H+ gradient-driven dipeptide reabsorption in proximal tubule of rat kidney. Studies in vivo and in vitro. Am J Physiol. 1987;253:F448–F457. [PubMed]
  • Skopicki H, Fisher K, Zikos D, Bloch R, Flouret G, Peterson D. Multiple carriers for dipeptide transport: Carriermediated transport of glycyl-L-proline I renal BBMV. Am J Physiol. 1991;261:F670–F678. [PubMed]
  • Siwiora S, Fingberg M, Büntemeyer H, Lehmann J. Inhibitory substance(s) secreted in cell culture media of recombinant CHO and a hybridoma cell line. In: Spier RE, Griffiths JB, Berthold W, editors. Animal Cell Technology Products of Today, Prospects for Tomorrow. Oxford: Butterworth Heinemann Ltd.; 1994. pp. 167–169.
  • Xie L, Nyberg G, Gu X, Li H, Möllborn F, Wang D. Gamma-Interferon production and quality in stoichiometric fedbatch cultures of chinese hamster ovary (CHO) cells under serum-free conditions. Biotechnol Bioeng. 1997;56:577–582. [PubMed]
  • Zhang Y, Zhou Y, Yu J. Effects of peptone on hybridoma growth and monoclonal antibody formation. Cytotechnology. 1994;16:147–150. [PubMed]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.